Fortress Biotech
FBIO • NASDAQ
Fortress Biotech is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lindsay Allan Rosenwald, with a market cap of $90.9M.
CEOLindsay Allan Rosenwald
Market Cap$90.9M
Biotechnology
Healthcare
Employees186.0
Websitefortressbiotech.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Fortress Biotech
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
$0.23
Revenue Estimate
$29.1M
Earnings History
Past 12 earnings reports for Fortress Biotech
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | $0.11Est: -$0.55 | +120.0% | $17.6MEst: $22.1M | -20.2% |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.46Est: -$0.31 | -48.4% | $16.4MEst: $14.5M | +13.2% | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.48 | — | $13.1M | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.26Est: -$0.75 | +65.3% | $15.1MEst: $15.6M | -3.0% | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.76Est: -$0.59 | -28.8% | $14.6MEst: $32.2M | -54.6% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.73Est: -$1.23 | +40.7% | $14.9MEst: $14.8M | +0.8% | 10-Q |
| May 15, 2024 | Q1 2024 | -$1.03Est: -$1.73 | +40.5% | $13.0MEst: $14.1M | -7.8% | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.53Est: -$1.97 | +73.1% | $19.9MEst: $14.9M | +34.0% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.94Est: -$3.21 | +70.7% | $34.8MEst: $14.6M | +138.4% | — |
| Aug 14, 2023 | Q2 2023 | -$1.05Est: -$3.45 | +69.6% | $17.4MEst: $17.5M | -0.4% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.90Est: -$3.00 | +70.0% | $12.4MEst: $20.3M | -38.7% | 10-Q |
| Mar 30, 2023 | Q4 2022 | -$1.20Est: -$0.22 | -445.5% | $16.4MEst: $22.1M | -25.6% | — |